167
Views
9
CrossRef citations to date
0
Altmetric
Thyroid Carcinoma

Management and follow-up results of an incidental thyroid carcinoma in a young woman with ovarian teratoma

, , , , , , & show all
Pages 724-726 | Received 31 Jan 2013, Accepted 18 Apr 2013, Published online: 18 Jun 2013

References

  • Zhang X. Thyroid type carcinoma of struma ovarii. Arch Pathol Lab Med 2010;134:786–91
  • Wolff EF, Hughes M, Merino MJ, et al. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer. Thyroid 2010;20:981–7
  • Dos Santos L, Mok E, Iasonos A, et al. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature. Gynecol Oncol 2007;105:321–4
  • Guanipa Sierra W, Fernandez Caterina P, Avarez Martinez M, Figueora Lopez R. Struma ovarii with malignant histology: a case of papillary thyroid carcinoma. Endocrinol Nutr 2011;58:48–51
  • Menon S, Deodhar K, Rekhi B, et al. Unilateral malignant struma ovarii in a case of bilateral ovarian teratoma with raised CA-125 level: a rare case with treatment dilemmas. Indian J Pathol Microbiol 2011;54:578–80
  • Kraemer M, Grischke EM, Staebler A, et al. Laparoscopic excision of malignant struma ovarii and 1 year follow-up without further treatment. Fertil Steril 2011;95:2124:e9–12
  • Matsuda K, Maehama T, Kanazawa K. Malignant struma ovarii with thyrotoxicosis. Gynecol Oncol 2001;82:575–7
  • Doldi N, Taccagni GL, Basin M, et al. Hashimoto’s disease in a papillary carcinoma of the thyroid originating in teratoma of the ovary. Gynecol Endocrinol 1998;12:41–2
  • Soyluk O, Boztepe H, Aral F, et al. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distincly low thyroglobulin at initial assessment. Thyroid 2011;21:1301–8
  • Wolff EF, Hughes M, Merino MJ, et al. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer. Thyroid 2010;20:981–7
  • Van Wijk JP, Broekhuizen de-Gast HS, Smits AJ, et al. Scintigraphic detection of benign ovarian teratoma after total thyroidectomy and radioactive iodine for differentiated thyroid cancer. J Clin Endocrinol Metab 2012;97:1094–5
  • Laksmanan M, Reynolds JC, Del Vecchio S, et al. Pelvic radioiodine uptake in a rectal wall teratoma after thyroidectomy for papillary thyroid carcinoma. J Nucl Med 1992;33:1848–50
  • DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I-131 therapy. Gynecol Oncol 2003;89:543–8
  • Salman WD, Singh M, Twaij Z. Case of papillary thyroid carcinoma in struma ovarii and review of the literature. Patholog Res Int 2010;2:352476
  • Dane C, Ekmez M, Karaca A, et al. Follicular variant of papillary thyroid carcinoma arising from a dermoid cyst: a rare malignancy in young women and review of the literature. Taiwan J Obstet Gynecol 2012;51:421–5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.